Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.
Press releases published on July 31, 2025

Zoom to Release Financial Results for the Second Quarter of Fiscal Year 2026
SAN JOSE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ: ZM) today announced it will release its financial results for the second quarter of fiscal year 2026 on Thursday, August 21, 2025, after the market closes. A live Zoom …

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level 4D-150 demonstrated durable and dose-dependent clinical activity with sustained gains in visual acuity and anatomic control Phase 3 dose (3E10 vg …

iRhythm Technologies Announces Second Quarter 2025 Financial Results
SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the …

GSI Technology, Inc. Announces First Quarter Fiscal 2026 Results
SUNNYVALE, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its first fiscal quarter ended June 30, 2025. Summary Comments for First Quarter Fiscal Year 2026 SRAM revenue increased 7% …

Rackspace Receives SBTi Approval for Net-Zero Targets, Reinforcing Commitment to Sustainable Operations and Innovation
SAN ANTONIO, July 31, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end hybrid cloud and AI solutions company, announced today that the Science Based Targets Initiative (SBTi) has approved its near-term, long-term, and net- …

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
Company expects to complete Phase 3 Aspire study in the second half of 2026 Aurora study of GTX-102 in additional ages and genotypes on track to initiate in the second half of 2025 NOVATO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical …

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second quarter 2025 financial results after the markets close on …

Flight disruptions have dropped, but millions of UK travellers could be missing out on compensation
Over 75K EU flights delayed in 2025—passengers owed up to €600 each under EU261. Skycop reveals €2.2B in unclaimed compensation. Check eligibility now! VILNIUS, LITHUANIA, July 31, 2025 /EINPresswire.com/ -- Millions of Passengers Might Be Owed Hundreds …

Valtriora Capital dévoile VTRC IA 4.0, fruit du travail de Pascal Martin
Valtriora Capital va lancer VTRC IA 4.0, un système d’investissement intelligent conçu avec le professeur Pascal Martin, analyste en chef de la société. PARIS, FRANCE, July 31, 2025 /EINPresswire.com/ -- Valtriora Capital, acteur de premier plan dans la …

Acquisition of The Lens Project: Call for Expressions of Interest
Cambia seeks expressions of interest from qualified and aligned organisations or individuals for the acquisition of The Lens. CANBERRA, ACT, AUSTRALIA, July 31, 2025 /EINPresswire.com/ -- Cambia, a non-profit social enterprise based in Australia, is …

OrbimountAI Amplia la Cobertura de Senales Bursatiles Automatizadas en Intercambios Globales
RIGA, LATVIA, July 31, 2025 /EINPresswire.com/ -- OrbimountAI ha anunciado una ampliacion de su sistema automatizado de senales bursatiles, extendiendo su cobertura hacia una red mas amplia de intercambios internacionales. Este avance busca dar respuesta …

MulfinTradeAi startet fortschrittliche KI Aktien Signal Engine fuer globale Investoren
LONDON, UNITED KINGDOM, July 31, 2025 /EINPresswire.com/ -- MulfinTrade hat die Einfuehrung seiner neuen MulfinTradeAi Plattform bekanntgegeben, die eine KI basierte Signal Engine fuer den weltweiten Aktienhandel bereitstellt. Ziel ist es, durch praezise …

Fintrex Velocity Sets New Standard in High-Speed Financial Transactions
LONDON, UNITED KINGDOM, July 31, 2025 /EINPresswire.com/ -- In todays fast paced trading environment the ability to process and act on information with speed and precision has become a defining factor for market performance. Fintrex Velocity has …

Orchestra BioMed Announces Proposed Public Offering
NEW HOPE, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
• Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to invest $10 million in an equity private placement and an …

Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
COPENHAGEN, Denmark, July 31, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter 2025 financial results and provide a business update on Thursday, August 7, 2025, after the close of the U.S. financial …

Asure Announces Second Quarter 2025 Results
Second Quarter 2025 Total Revenues Increased 7% to $30.1 million Recurring Revenues Grew 6% from Prior Year AUSTIN, Texas, July 31, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (“we”, “us”, “our”, “Asure” or the “Company”) (Nasdaq: ASUR), a leading …

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management …

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 7, 2025 at 4:30 pm ET …

Ruanyun Edai Technology Announces Financial Results for Fiscal Year 2025
NANCHANG, China, July 31, 2025 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (“Ruanyun” or the “Company”) (NASDAQ: RYET), a leading AI-powered education technology company in China, today announced its financial results for the fiscal year ended March …